IPO - Nuo Therapeutics, Inc.

Form Type: S-3/A

Filing Date: 2025-05-09

Corporate Action: Ipo

Type: New

Accession Number: 000143774925015586

Filing Summary: Nuo Therapeutics, Inc. has filed a Pre-Effective Amendment No. 1 to Form S-3 registration statement with the SEC, indicating its intention to offer up to $15,000,000 in common stock. The company focuses on developing and marketing innovative cell-based medical technologies. Notably, their current commercial product is the Aurix System, a technology used for chronic wound care. The document outlines the offering process, including potential sales methods such as through agents, underwriters, or directly to purchasers. As of May 7, 2025, the last sale price of their common stock was reported at $1.65 with a total market value of $45.2 million based on outstanding shares. The prospectus also highlights risk factors associated with investment and informs that the registration may be subject to modification before it becomes effective.